STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO)

Serial Number 97163869
Registration 7210095
700

Registration Progress

Application Filed
Dec 9, 2021
Under Examination
Approved for Publication
Aug 22, 2023
Published for Opposition
Aug 22, 2023
Registered
Nov 7, 2023

Trademark Image

STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO)

Basic Information

Serial Number
97163869
Registration Number
7210095
Filing Date
December 9, 2021
Registration Date
November 7, 2023
Published for Opposition
August 22, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 7, 2023
Registration
Registered
Classes
035 042

Rights Holder

Boston Biotech Clinical Research, LLC

16
Address
95 Elliot St
Natick, MA 01760

Ownership History

Boston Biotech Clinical Research, LLC

Original Applicant
16
Natick, MA

Boston Biotech Clinical Research, LLC

Owner at Publication
16
Natick, MA

Boston Biotech Clinical Research, LLC

Original Registrant
16
Natick, MA

Legal Representation

Attorney
Michelle Rosenberg

USPTO Deadlines

Next Deadline
1563 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-11-07)
Due Date
November 07, 2029
Grace Period Ends
May 07, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Nov 7, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 7, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 22, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 22, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 2, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 18, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 18, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jul 18, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 18, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 18, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 3, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
May 3, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
May 3, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 14, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 14, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 16, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 16, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 16, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 17, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 14, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 13, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business consulting and management in the field of medical and scientific research and development and clinical trials for biotechnology, pharmaceutical, and medical device companies, namely, assisting companies with developing business strategies and road maps for medical and scientific research and development; assisting companies in the nature of business advisory services in the field of business plan development for biotechnology, pharmaceutical, and medical device companies; assisting companies with trial feasibility in the nature of providing independent review of clinical trials for business purposes; assisting companies with clinical trials compliance, in the nature of business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials, and applications for drug approval; business concept development and implementation in the field of the pharmaceutical industry; business consulting and management in the field of clinical trials, namely, providing information management services; business management and development consulting services for clinical research organizations (CRO), drug manufacturers, and providing in-house and out-sourced business functions and activities, namely, outsourcing services and office administration services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of biopharmaceutical companies to assist them with clinical research, clinical trials, and applications for drug approval in the fields of genetics, epigenetic, biologics and small molecule therapeutics, drugs, combination drug and device products; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; and assisting companies with developing global regulatory approval strategies and navigating the regulatory submission and approval process, all in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
First Use Anywhere: 20090300
First Use in Commerce: 20090300
Class 042
Providing medical and scientific research information in the field of clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials
First Use Anywhere: 20090300
First Use in Commerce: 20090300

Additional Information

Pseudo Mark
STRATEGIC CLINICAL INNOVATION ORGANIZATION STRATEGIC CLINICAL INNOVATION ORGANIZATION

Classification

International Classes
035 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"STRATEGIC CLINICAL INNOVATION ORGANIZATION"